Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03081026 · ClinicalTrials.gov registry record
Transphyseal Vs. Physeal Sparing ACL Reconstruction in Skeletally Immature Patients: Risk of Subsequent Lower Extremity Growth Deformity
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 49
- Enrollment target
NCT03081026: Completed study, sponsored by Duke University.
NCT03081026 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03081026 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
To assess the risk of lower extremity angular growth deformity following anterior cruciate ligament (ACL) reconstructions in young patients who are not yet skeletally mature. The study will compare two surgical techniques (physeal sparing vs transphyseal).
Primary Outcome
Bilateral hip to ankle radiographs measurements.
Interventions
- DIAGNOSTIC_TEST Bilateral hip to ankle x-ray, exam and strength testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-03-06 |
What the finished NCT03081026 record still lists
NCT03081026 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Bilateral hip to ankle x-ray, exam and strength testing. is the first listed.
NCT03081026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03081026 about?
NCT03081026 is a clinical study titled "Transphyseal Vs. Physeal Sparing ACL Reconstruction in Skeletally Immature Patients: Risk of Subsequent Lower Extremity Growth Deformity". To assess the risk of lower extremity angular growth deformity following anterior cruciate ligament (ACL) reconstructions in young patients who are not yet skeletally mature. The study will compare two surgical techniques (physeal sparing vs transphyseal).
What is the current status of trial NCT03081026?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2017-05-01. Estimated completion is 2020-03-06.
What interventions are being tested in trial NCT03081026?
The interventions under investigation include: Bilateral hip to ankle x-ray, exam and strength testing. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03081026?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI